Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-011298·ASTRAZENECA PLC
Schedule 13D ownership disclosure
Innate Pharma SA
Ordinary Shares, EUR0.05 nominal value per share · CUSIP: 45781K105
Event date: 2025-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AstraZeneca PLCReported CIK 0000901832
Shares: 7,825,501.00 · Class: 8.3%
- MedImmune LimitedReported CIK 0001790714
Shares: 7,825,501.00 · Class: 8.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-011298
- Form type
- SCHEDULE 13D/A
- Filer
- ASTRAZENECA PLC
- CIK
- CIK 901832
- Filed
- Feb 06, 2026
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13D beneficial ownership